SRRK logo

SRRK
Scholar Rock Holding Corp

2,303
Mkt Cap
$5.8B
Volume
1.05M
52W High
$51.63
52W Low
$27.07
PE Ratio
-13.31
SRRK Fundamentals
Price
$47.72
Prev Close
$48.38
Open
$48.01
50D MA
$46.86
Beta
1.25
Avg. Volume
1.48M
EPS (Annual)
-$3.30
P/B
20.59
Rev/Employee
$0.00
$4,793.94
Loading...
Loading...
News
all
press releases
Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference
Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its leading platform in myostatin biology to advance...
News Placeholder
More News
News Placeholder
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Scholar Rock (NASDAQ: SRRK; the Company) today announced that the company granted inducement equity awards covering an aggregate of 38,481 shares of its common stock to six newly hired employees, consisting of inducement stock options to purchase an aggregate of 12,061 shares of common stock and...
News Placeholder
Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights
Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and...
News Placeholder
Jennison Associates LLC Acquires 1,188,676 Shares of Scholar Rock Holding Corporation $SRRK
Jennison Associates LLC grew its holdings in Scholar Rock Holding Corporation (NASDAQ:SRRK - Free Report) by 74.0% during the 4th quarter, according to the company in its most recent filing with the...
News Placeholder
Scholar Rock (SRRK) Projected to Post Earnings on Thursday
Scholar Rock (NASDAQ:SRRK) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at...
News Placeholder
Scholar Rock to Present at the BofA Securities 2026 Health Care Conference
Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and...
News Placeholder
Pictet Asset Management Holding SA Sells 126,964 Shares of Scholar Rock Holding Corporation $SRRK
Pictet Asset Management Holding SA trimmed its stake in Scholar Rock Holding Corporation (NASDAQ:SRRK - Free Report) by 9.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,195,967 shares of the company's stock after sellin...
News Placeholder
David Hallal Sells 30,615 Shares of Scholar Rock (NASDAQ:SRRK) Stock
Scholar Rock Holding Corporation (NASDAQ:SRRK - Get Free Report) CEO David Hallal sold 30,615 shares of the firm's stock in a transaction that occurred on Thursday, April 16th. The shares were sold...
News Placeholder
Akshay Vaishnaw Sells 12,246 Shares of Scholar Rock (NASDAQ:SRRK) Stock
Scholar Rock Holding Corporation (NASDAQ:SRRK - Get Free Report) insider Akshay Vaishnaw sold 12,246 shares of the firm's stock in a transaction that occurred on Thursday, April 16th. The stock was...
News Placeholder
Vikas Sinha Sells 10,410 Shares of Scholar Rock (NASDAQ:SRRK) Stock
Scholar Rock Holding Corporation (NASDAQ:SRRK - Get Free Report) CFO Vikas Sinha sold 10,410 shares of the stock in a transaction dated Thursday, April 16th. The shares were sold at an average price...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available